Taiwan FDA registration d574c699a44cb313c939ab2f963af141
Aoshi subtilin 0.05 unit identification paper ingot
TW: 傲世 枯草菌素0.05單位鑑定用紙錠
Taiwan·Risk Class 1·OXOID LIMITED·Registered Mar 22, 2006 – Mar 22, 2011CancelledRegistration details
- Analysis ID
- d574c699a44cb313c939ab2f963af141
- Customs Code
- DHA04400307806
Company information
- Manufacturer
- OXOID LIMITED
- Manufacturer Country
- United Kingdom
- Authorized Representative
- Qixin Biotechnology Co., Ltd
Product details
- Intended Use
- Distinguish between Lancefield group A streptococci and other β hemolytic streptococci.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.2660 微生物鑑別及測定器材
- Import Information
- import
Dates and status
- Registration Date
- Mar 22, 2006
- Expiry Date
- Mar 22, 2011
- Cancellation Date
- Nov 08, 2012
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Aoshi subtilin 0.05 unit identification paper ingot in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number d574c699a44cb313c939ab2f963af141 and manufactured by OXOID LIMITED. The authorized representative in Taiwan is Qixin Biotechnology Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices